Weight Loss Supplement

Hydroxycut With Ephedra

28 adverse event reports submitted to the FDA · 2010–2017 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 28 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Emotional Distress

Injury

Pain

Liver Injury

Anxiety

Liver function test abnormal

Hepatocellular Injury

Convulsion

Renal Disorder

Renal Failure

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

Outcome	Reports
Other Serious or Important Medical Event	26
Hospitalization	13
Visited a Health Care Provider	10
Disability	3
Required Intervention	3
Life Threatening	1
Death	1
Congenital Anomaly	1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18

18–34

35–49

50–64

65–79

80+

Unknown

14 reports had age data; 14 unknown.

Gender

Unknown/Not Reported

Female

Male

Reports by Year

Annual report counts from 2010–2017. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'10

'11

'12

'13

'14

'15

'16

'17

Hover bars for exact counts.

Context about this data: Reports concentrated in 2012 (50% of total, spanning 2010–2017), suggesting a reporting event during that period rather than evenly distributed consumer use.

← View all Hydroxycut products in FDA data

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗ · About our methodology · How to read this data